Crossmark

Therapeutic potential of esculetin in attenuating kidney and heart damage caused by cyclophosphamide: insights into NRF2 activation and NLRP3 inhibition

Crossref DOI link: https://doi.org/10.1007/s13273-025-00579-2

Published Online: 2025-09-28

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Srirangan, Prathap

Shyam, Mukul

Radhakrishnan, Vidya

Ghosh, Shankha Shubhra

Prince, Sabina Evan https://orcid.org/0000-0003-2073-5971
Funding

Funding for this research was provided by:

VIT University (VIT-EMPOWER/2025-26/007)
License Information

Text and Data Mining valid from 2025-09-28

Version of Record valid from 2025-09-28
More Information

Article History

Received: 24 April 2025

Revised: 11 September 2025

Accepted: 18 September 2025

First Online: 28 September 2025

Declarations

:

: This study was approved by the Institutional Animal Ethical Committee of VIT (VIT/IAEC/23/May23/08) and adhered to the CPCSEA guidelines.

: The authors declare that there are no competing interests.

Document is current

Any future updates will be listed below